Laurence E. Krieger
Impact in
Papers in
- Co-authors
- Girish S. Kulkarni (8 shared papers)Ronald de Wit (11 shared papers)Ashish M. Kamat (10 shared papers)Eric A. Singer (11 shared papers)Petros Grivas (11 shared papers)Dean F. Bajorin (11 shared papers)Hiroyuki Nishiyama (10 shared papers)Edward Uchio (11 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)Annals of Oncology (4 papers)Clinical Genitourinary Cancer (1 paper)The Journal of Urology (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- AustraliaUnited StatesNetherlands
In The Last Decade
Laurence E. Krieger
23 papers receiving 541 citations
Laurence E. Krieger's Hit Papers
Peers
Comparison fields: 5 of 32
- Surgery 453
- Urology 40
- Oncology 169
- Pulmonary and Respiratory Medicine 72
- Immunology 37
Countries citing papers authored by Laurence E. Krieger
This map shows the geographic impact of Laurence E. Krieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence E. Krieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence E. Krieger more than expected).
Fields of papers citing papers by Laurence E. Krieger
This network shows the impact of papers produced by Laurence E. Krieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence E. Krieger. The network helps show where Laurence E. Krieger may publish in the future.
Co-authors
The 25 scholars most cited alongside Laurence E. Krieger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study Hit paper breakdown → | 2021 | 345 |
| 2 | 2019 | 85 | |
| 3 | 2020 | 23 | |
| 4 | 2023 | 12 | |
| 5 | 2018 | 11 | |
| 6 | 2023 | 10 | |
| 7 | 2023 | 9 | |
| 8 | 2024 | 7 | |
| 9 | 2021 | 7 | |
| 10 | 2015 | 7 | |
| 11 | 2019 | 4 | |
| 12 | 2019 | 4 | |
| 13 | 2025 | 3 | |
| 14 | 2019 | 3 | |
| 15 | 2019 | 3 | |
| 16 | 2020 | 2 | |
| 17 | 2021 | 2 | |
| 18 | 2020 | 2 | |
| 19 | 2022 | 2 | |
| 20 | 2020 | 1 |
About Laurence E. Krieger
Laurence E. Krieger is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Biotechnology, having authored 28 papers that have together received 545 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (18 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Research and Treatments (9 papers), Epigenetics and DNA Methylation (6 papers), Renal cell carcinoma treatment (5 papers), Prostate Cancer Treatment and Research (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Surgery (453 citations), Urology (40 citations), Oncology (169 citations), Pulmonary and Respiratory Medicine (72 citations) and Immunology (37 citations). Laurence E. Krieger has collaborated with scholars based in Australia, United States and Netherlands. Frequent co-authors include Girish S. Kulkarni, Ronald de Wit, Ashish M. Kamat, Eric A. Singer, Petros Grivas, Dean F. Bajorin, Hiroyuki Nishiyama, Edward Uchio, Ekta Kapadia and Ho Kyung Seo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Genitourinary Cancer, The Journal of Urology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.